Pharmaceutical

UK MHRA approves Advanz Pharma antibiotic for complex infections

The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.

Apr 7, 2024 - 00:00
UK MHRA approves Advanz Pharma antibiotic for complex infections
The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.
Read the original article

Tags:

Previous Article

Caris and Merck KGaA link to develop ADCs for cancer treatment

Next Article

Q&A: BARDA wants to back tech that can combat multiple infections, says director

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Fiery MedPAC meeting highlights massive overpayments in Medicare Advantage

STAT+: Fiery MedPAC meeting highlights massive overpaym...

Jan 12, 2024

STAT+: Novo says oral version of Ozempic leads to 15% weight loss

STAT+: Novo says oral version of Ozempic leads to 15% w...

May 23, 2023

EC grants approval to Merck’s Keytruda for gastric cancer

EC grants approval to Merck’s Keytruda for gastric cancer

Aug 30, 2023